Renal Cancer - Results from #4220

Hypertension and diabetes mellitus are not associated with worse renal functional outcome after partial nephrectomy in patients with normal baseline kidney function October 10, 2018

CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients October 10, 2018

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma October 10, 2018

Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase 2 study October 9, 2018

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date October 9, 2018

Increasing kidney cancer incidence and survival in Estonia: role of age and stage October 9, 2018

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy October 8, 2018

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma October 8, 2018

Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease October 8, 2018

Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma October 8, 2018

Biomarkers and new therapeutic targets in renal cell carcinoma October 5, 2018

Re-irradiation for painful bone metastases using stereotactic body radiotherapy October 5, 2018

Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study October 5, 2018

Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy October 4, 2018

Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature October 4, 2018

RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma October 4, 2018

Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence October 4, 2018

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) October 4, 2018

Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN October 3, 2018

Primary renal angiosarcoma: a diagnostic and therapeutic challenge October 3, 2018

Page 212 of 459